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Macroautophagy is a general term for a cellular facility for the degradation within 
lysosomes of cytoplasmic components including whole organelles. As a basal 
process, it is essential for homeostasis and is functional in most cells all the 
time, but it is also an option for implementing appropriate responses to stress. 
The purpose of this review is to draw attention to findings which show that 
autophagy proteins can act to modulate and amplify the activities of 
transcription factors involved in stress response such as the p53, FOXO, 
MiT/TFE, Nrf2 and NFκB/Rel families. Thus, transcription factors not only amplify 
stress responses and autophagy, but are themselves subject to retrograde 
regulation by autophagy-related proteins. Physical interactions with autophagy-
related proteins, competition for activating intermediates, and “signalphagy”, 
which is the role autophagy plays in the degradation of specific signaling 
proteins, together provide powerful tools for implementing negative feedback or 
positive feed forward loops on transcription factors which regulate autophagy. 
Here we present examples illustrating how this network works together to 
regulate metabolic and physiologic responses.  
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Introduction 
Macroautophagy (hereafter designated simply autophagy) is a catabolic process that 
sequesters cytoplasmic elements in double membrane vacuoles for degradation in 
lysosomes. Targets of autophagy can be particular, specific proteins, unspecific protein 
aggregates, or whole organelles, e.g. dysfunctional mitochondria. Basal autophagy is 
constitutive in most cell types (1-3) and it is estimated that basal autophagy is 
responsible for the catabolism of 1 - 1.5% of cellular protein per hour even under 
nutrient-rich conditions (4). However, since cell survival is constantly threatened by 
variations in both internal and external conditions, coherent autophagy programs must 
be able to respond appropriately to stress. Stresses, such as starvation, whether for 
nutrients or for appropriate growth factors, metabolic imbalance, hypoxia, oxidative 
stress, genotoxic stress, or unfolded-protein stress all impact on autophagy and induce 
adjustments, initially through post-translational modifications among the autophagy 
related (ATG) proteins, but extending then to transcription factors, e.g. those of the 
p53, Forkhead box O (FOXO), Microphthalmia/Transcription Factor E (MiT/TFE), 
nuclear factor erythroid-derived 2-related factor 2 (Nrf2) and Nuclear Factor kappa-
light chain enhancer of activated B cells (NFκB)/ reticuloendotheliosis (Rel) families 
(2,5-9). 
The identification of the ATG genes, first in yeast, then in mammals, provided 
the impetus for a molecular understanding of autophagy (4,10). Autophagy functions 
have been conserved in evolution from Saccharomyces to man; there are now more 
than 30 recognized ATG genes, some of which bear for historical reasons individual 
names, e.g. Beclin 1, p62/SQSTM1, FIP200 (focal adhesion kinase family-interacting 
protein of 200 kD) whose products are required for autophagy. The canonical 
autophagic pathways (10-13), and also non-canonical pathways resembling or 
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overlapping with autophagy (14-16), have been characterized in excellent reviews; 
hence, they will not be elaborated here.  
Autophagy is a part of a complex network bringing together the regulation of 
stress responses, metabolic oversight, and cell proliferation. This network includes 
interactions which connect many familiar, linear pathways (6-9,11,12). An integrated 
picture showing how the separate pathway fragments fit together in a whole network 
is surely an important goal for future research because there exists an evident clinical 
potential for targeting events in autophagy, especially for treatment of 
neurodegenerative and cardiovascular diseases or cancer. Various retrograde 
interactions between ATG proteins and transcription factors provide already hints 
about how this network may work and will be the subject of this review. 
 
Stresses Trigger Autophagy 
The central role of mTORC1 in the regulation of autophagy 
Autophagy is a specific, modulated response after stresses such as nutrient starvation, 
growth/survival factor deprivation or the hyperproliferative stimulus induced by 
oncogenes, e.g. activated Ras (17-20). An ultimate target in all forms of stress is the 
multi-protein, mechanistic Target of Rapamycin Complex 1 (mTORC1), a master 
regulator of cell growth which integrates inputs from at least five pathways: growth 
factor stimulation, DNA damage, energy charge (ratio of ATP to AMP), sufficiency of 
amino acids and availability of oxygen (Fig. 1) (21-23). MTORC1 is made up of the 
Target of Rapamycin (TOR), a serine/threonine protein kinase, together with several 
regulatory subunits and the scaffold protein Raptor. MTORC1, localized in part on the 
5 
 
lysosome, is responsible for phosphorylating numerous targets including regulators of 
translation such as the ribosomal S6 kinase and the initiation factor eIF4E binding 
protein, 4E-BP1, to promote protein synthesis, but at the same time it negatively 
regulates autophagy by direct phosphorylation and inactivation of the unc-51-like 
kinases 1 and 2 (ULK1/2) and ATG13 of the phagophore initiation complex (22). Raptor 
is responsible for mTORC1 binding to the small GTPase Rag proteins associated with 
the Ragulator complex, and to Rheb (Ras homolog enriched in brain), which is also a 
small GTPase (22). All of these small GTPases are located at the lysosome which thus 
serves as a critical platform for regulation of mTORC1 activity (24-26).  MTORC1 is 
active while tethered to the lysosome in association with the Rag and Rheb small 
GTPases, but since Rag GTPases bind to mTORC1 based on information about intra-
lysosomal concentrations of amino acids communicated by the proton pump channel 
v-ATPase (27), mTORC1 becomes inactivated immediately under conditions of 
insufficient amino acids (25,27). Rag GTPases then release mTORC1, which is 
displaced from the lysosome and inactivated (25).  
As with Rag-dependent monitoring of amino acid starvation, other inputs on 
mTORC1 are regulated by the Rag-dependent recruitment of the Tuberous Sclerosis 
Complex (TSC) containing TSC1 and TSC2, to the lysosome (25). The TSC1/2 
complex is a GTPase activating protein (GAP); its association with the Rag GTPases 
brings it into proximity with Rheb (25). The GTP-bound form of Rheb is essential for 
mTORC1 activity, but is converted by an active TSC1/2 GAP to the GDP-bound form, 
followed by mTORC1 inactivation (24,25).  Since however, TSC1/2 is under the subtle 
and varied control of the growth factor receptor (e.g. insulin) - PI3K - AKT pathway its 
activity is inhibited by AKT phorphorylation (22,23). On the other hand, other signals 
acting on the AMP-dependent protein kinase (AMPK) such as low oxygen tension, low 
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energy charge or increased levels of reactive oxygen species (ROS), provide a strong 
TSC1/2 activation (Fig. 1), thus provoking conversion of Rheb to the GDP-bound form 
with concomitant mTORC1 inactivation, displacement from the lysosome, and the 
initiation of autophagy in consequence (22,25). 
AMPK a complex of 3 proteins and has a central responsibility for regulating 
energy charge by continuously monitoring the [AMP] / [ATP] ratio. As shown in Fig. 1, 
AMPK is also able to integrate information from various pathways. Glucose starvation, 
i.e. a rising [AMP] / [ATP] ratio, is an alarm signal, but also sestrin transactivation by 
p53 in response to stress activates AMPK (28,29), as does its phosphorylation by a 
p53-dependent activation of Liver B1 kinase (LKB1) (30,31) or by oxidized ataxia 
telangiectasia mutated (ATM) kinase dimers formed in the cytoplasm in the presence 
of reactive oxygen species (ROS) (32). 
Autophagic responses are induced by many kinds of stress other than just 
starvation. However, since almost all stress responses overlap largely with the 
phenotype seen after starvation; the induction of autophagy is a central feature (33,34). 
This is because in practically all forms of stress a common denominator is the 
increased formation of ROS, which is released by the mitochondria as a consequence 
of almost any dysfunction or metabolic deficiency or imbalance, triggering autophagy 
(34-36). 
 
The DNA damage response and p53 
Fig. 1 also illustrates the DNA damage response (DDR) and indicates the triggers (red 
arrows) which are focused on the AMPK complex leading to initiation of autophagy, 
but potentially also to apoptosis. DDR is a prototype stress response made up of 
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several tasks: sensing DNA damage, its repair, and making physiological corrections 
like arresting proliferation and responding to increased metabolic demands with 
autophagy (37). Typical is the response to potentially lethal DNA double strand breaks 
caused by ionizing radiation and by some chemotherapy drugs. Briefly, such DNA 
strand breaks lead to the activation of the large (350 kD) serine/threonine protein 
kinase ATM which serves as master regulator and transducer (Fig. 1) for repair (37), 
but also acts in the stress response. ATM is activated by the formation of the Mre11-
Rad50-NbsI (MRN) complex bound to the ends of DNA breaks and is essential for 
repair (38). Moreover, poly ADP-ribose polymerase 1 (PARP1) activation at DNA 
strand breaks produces chains of poly ADP-ribose (PAR) marking the site of injury. 
PARP1 activation is believed to be physiologically important owing to a bioenergetic 
collapse which can follow upon the massive ATP and NAD+ consumption (37,39), and 
because PAR binds to and inhibits hexokinase (40), hence inhibiting the first step in 
glycolysis. Following PARP1 activation, a sharp rise in the [AMP] / [ATP] ratio and also 
increased mitochondrial ROS output, lead then to AMPK activation followed by 
mTORC1 inactivation and autophagy as in starvation.  
A broad phosphorylation cascade is initiated by ATM in the nucleus following its 
activation, monomerization and autophosphorylation at several sites. The ATM kinase 
phosphorylates numerous targets (Fig. 1), e.g. locally, on the DNA such as on histone 
2AX (H2AX), and on checkpoint 2 protein kinase (Chk2), which then, in turn is 
responsible for a rapid activating phosphorylation of p53 (41,42). Phosphorylation of 
human p53 at ser20 by Chk2 is believed to be important for its transactivation of 
p21CDKN1A and other stress response targets (43). However, concomitant with 
phosphorylation, p53 tetramerization is essential for its activation (44,45). 
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Noteworthy is the fact that following glucose starvation, human p53 is also 
subject to phosphorylation and activation from downstream by AMPK (see yellow 
arrow originating at AMPK; Fig. 1) (46-48). The tumor suppressor protein p53 is of 
particular importance in all forms of stress, partly because it is a transcription factor 
with broad responsibility for the oversight of cellular metabolism, autophagy and 
apoptosis (49-52) and partly because it has, as will be discussed below, important 
functions as an effector in the cytoplasm. After stress, transactivation of p21CDKN1A by 
p53 (Fig. 1) contributes to G1 and G2 cell cycle arrest, while other p53 targets, e.g. 
sestrins, promote autophagy and a conservative, catabolic metabolism by activating 
AMPK (28,53) and the lysosomal damage-regulated autophagy modulator (DRAM-1) 
protein (54,55), potentially contributes to either autophagy or apoptosis. Another p53 
transcriptional target, TP53-induced glycolysis and apoptosis regulator (TIGAR), acts 
counter to autophagy, reducing ROS levels by increasing flux through the pentose 
phosphate pathway with concomitant NADPH production needed to scavenge ROS 
with reduced glutathione (49). Finally, among the many other genes transactivated by 
p53 under stress conditions, several, like Puma, Noxa and Bax, are pro-apoptotic 
(2,35). 
After stress, phosphorylated, activated p53 can also be found in the cytoplasm 
(Fig. 1) where it acts, not as a transcription factor, but as a positive effector for 
autophagy, complexing with and activating LKB1 and triggering its phosphorylation of 
AMPK (30,31). Furthermore, under stress, such activated p53 can also take on a direct 
apoptogenic role in mitochondria (56-58). 
Interestingly, however, in unstressed conditions, cytoplasmic p53 plays an 
entirely different role as an inhibitory effector of autophagy (Fig. 1) (59-61), at least 
partly owing to its binding to FIP200, an essential component of the ULK1/2 protein 
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kinase complex responsible for autophagy initiation (61,62). In stress-free conditions 
cytoplasmic p53 protein has a tonic, inhibitory influence on basal autophagy. Thus, 
experimental p53 depletion or treatment of unstressed cells with pifithrin-α, a p53 
transcriptional inhibitor, causes an increase in basal autophagy (59,60). One speaks 
of a dual role for p53 (59).  
 
Autophagy-Related Proteins Act Retrograde on 
Transcription Factors 
ATG7 is an essential accessory protein for p53 transactivation of p21 
If one takes the view that transcription factors act upstream of the proteins whose 
expression they control, then retrograde signaling means that these expressed 
products can act on and influence transcription factor function. Basal autophagy is 
believed to be maximal in the G1/S phase of cell cycle, being inhibited in G2/M, because 
“autophagic catabolism and growth associated anabolism are probably mutually 
exclusive” (63). Thus, it was unsurprising that after glucose or amino acid starvation of 
wild-type mouse embryonic fibroblasts (MEF), Lee et al. found that the fraction of cells 
entering into S phase declined by 60% within 3 hours (35). However, the same 
experiment performed with Atg7 knockout MEF cells showed a reduction of just 20%. 
In fact, these authors found that expression of the cyclin-dependent kinase inhibitor 
p21 was lacking in Atg7 knockout MEF cells, although as expected, starvation 
provoked its expression in wild-type MEF. The levels of p27kip, known to be regulated 
by the FOXO family of transcription factors, however, were comparable in the two cell 
types. With chromatin immunoprecipitation, Lee et al. showed that in wild-type MEF 
cells, endogenous Atg7 was present together with p53 on the p21CDKN1A gene promoter 
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(Fig. 2) (35). The same complex could be found in both the cytoplasm and nucleus, 
and its abundance increased after nutrient starvation as the cells entered growth arrest.  
Investigation of other ATG proteins such as Beclin 1 or Atg5 failed to reveal any 
similar physical association with p53. However, a subset of p53-regulated pro-
apoptotic genes, Puma, Noxa, Bax, showed after starvation enhanced RNA and 
protein levels in both Atg7 knockout and Atg5 knockout as compared to wild-type cells, 
suggesting that these ATGs normally have a negative influence on transactivation of 
these pro-apoptotic genes (35). The role of Atg7 in its interaction with p53 seems to be 
to promote p53 tetramer formation and is distinguishable from the E1 ligase-like 
enzymatic activity of Atg7 needed for autophagy. Atg7 mutants lacking the C-terminal 
cysteine active site and, thus, non-functional for conjugation reactions in autophagy, 
were still able to bind p53 and promote p21CDKN1A transactivation. Taken together, the 
findings of Lee et al. indicate that Atg7 acts as an accessory protein for p53 in the 
process of the p21CDKN1A gene transactivation (35), much like other known accessory 
proteins involved with other p53 targets (64,65). 
 
Ectopic ATG5 expression initiates a stress response 
The goal of most anti-cancer therapy protocols is to induce irreparable DNA damage 
in tumor cells. Such protocols inevitably produce a DDR with activation of ATM kinase, 
p53 and a full program of stress responses (66,67). Low, sub-lethal doses of the 
topoisomerase II inhibitor, etoposide, or the DNA cross-linking agent, cisplatin were 
shown recently to induce strong upregulation of both ATG5 and p53 expression, as 
well as activation/phosphorylation of the latter (68). In these experiments, apoptosis 
levels remained low, but cell cycle arrest for 48 – 72 hours was observed. A rapid 
increase in autophagic flux was also documented, but this autophagic response was 
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secondary to p53 and ATG5 upregulation since the latter occurred even when 
autophagy was blocked by treatment with the PI3K type 3 inhibitor, 3-methyladenine. 
Blocking autophagic flux with 3-methyladenine, however, elicited a high level of 
caspase-dependent apoptotic cell death (68), which suggests that autophagy can be 
a preliminary to apoptosis. 
A surprising observation, however, was that simply expressing ATG5 ectopically 
in cells without drug treatment, also stimulated p53 upregulation, its phosphorylation 
and activation followed by p21CDKN1A transactivation (68,69). Thus, ectopically 
expressed ATG5 induces not just autophagy, but also an authentic stress response 
(Fig. 2), implying that ATG5 may impact on AMPK, since an upstream effect of 
activated AMPK on p53 has been documented (47). Exactly how this happens is 
unclear, but a feed-forward loop between p53 transactivation of sestrin, followed by 
AMPK potentiation and additional p53 activation, is proposed in Fig. 2 as a possible 
mechanism consistent with known pathways (46-48). Ectopically expressed Beclin 1, 
while able to trigger autophagy in Jurkat cells, failed to induce p53 activation or growth 
arrest (68). 
Interestingly, enforced ATG5 expression, besides causing autophagy and p53 
upregulation and activation, culminates in mitotic catastrophe (Fig. 2) (68). Within 72 
hours after ATG5 gene transfer, most cells exhibited evidence of mitotic catastrophe, 
i.e. were either multi-nucleate or exhibited enlarged, abnormal nuclei. An important 
insight into the mechanisms responsible emerged from cell fractionation studies using 
Jurkat cells (68,70). Unexpectedly, it was found that ATG5 localizes to a significant 
degree in the nucleus (Fig. 2). Beclin 1, had been previously reported to possess a 
homologous leucine-rich region acting as a nuclear export signal (71) and a 
homologous sequence was also detected in ATG5 (68). Both Beclin 1 (72) and ATG5 
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(68) have been found to physically associate with survivin/BIRC5 (Fig. 2). Since 
survivin/BIRC5 is an essential component of the chromosome passenger complex, 
competition between nuclear ATG5 and Aurora B for BIRC5 was shown to have 
consequences for recruitment of the chromosome passenger complex to centromeres 
during mitosis (68,70).  In cells ectopically-expressing ATG5, Aurora B was present at 
centromeres only in reduced amounts at prometaphase, whereas survivin/BIRC5 was 
present there in normal amounts, but afterward was retained at the centromeres at 
anaphase, unlike normal cells, which by that stage exhibited survivin/BIRC5 mainly at 
the central spindle (68). Any such disturbance in cytokinesis must lead to genetically 
abnormal cells, mitotic catastrophe, polyploidy, aneuploidy, imbalance in gene dosage, 
and eventually, in some fraction of the cells, to tumorigenesis (73). 
 
A feedback regulation by ATG7 on FOXO1 
FOXO transcription factors transactivate many genes involved in autophagy which 
represent survival responses to stress (ULK1, LC3, Gabarapl1, ATG5, ATG8, ATG12, 
ATG14, Beclin 1 and Bnip3) (74-76). 
 Interestingly, an interaction of ATG7 with FOXO1 was reported recently. ATG7 
is able to bind to acetylated FOXO1 in the cytoplasm (77-79), forming ATG7/FOXO1 
complexes which stimulate autophagy (Fig. 3). The accumulation of acetylated FOXO1 
in the cytoplasm takes place owing to a prior disassociation of Sirt2 deacetylase from 
FOXO1 under the influence of oxidative stress. In this role, FOXO1 acts as a 
cytoplasmic effector, not a transcription factor, since Zhao et al. could show that 
FOXO1 mutants defective for transcription factor activity retain the ability to bind ATG7 
and initiate autophagy (78). The induction of autophagy results presumably from the 
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activation of ATG7 in the ubiquitination-like conjugation reactions leading to formation 
of ATG5-ATG12 and LC3-phosphatidylethanolamine which are fundamental for the 
formation and closure of the autophagosome. At the same time, being complexed to 
ATG7, FOXO1 is thus retained in the cytoplasm transcriptionally inactive (Fig. 3). 
Hence, this phenomenon represents a kind of negative feedback on FOXO1 acting as 
a transcription factor.  
Furthermore, a tumor suppressive effect of this cytoplasmic FOXO1 function 
was also demonstrated, being ascribed to ATG7/FOXO1-induced autophagic cell death 
(78,80). Interestingly, Zhu et al. have reported that FOXO3 maintains a transcriptional 
repression on FOXO1 expression (Fig. 3) (81). These authors demonstrated that 
FOXO3 knockdown is followed by a spontaneous FOXO1-dependent upregulation of 
autophagy.   
 
P62-dependent selective autophagy creates feedback loops for Nrf2 
amplification in stress response pathways  
Autophagy is vitally important for the genetic stability of the cell. Early reports by 
Mathew et al. demonstrated that loss of functional autophagy causes genetic instability 
owing to accumulation of toxic p62/SQSTM1-target protein aggregates together with 
dysfunctional mitochondria and attendant elevated ROS production (82,83). It must be 
remembered that p62/SQSTM1 (hereafter designated just p62) is not just an 
autophagy receptor/adaptor; it is also a substrate that must be removed and degraded 
with the cargo via autophagy. Enforced p62 over-expression and accumulation 
induced ROS production, DNA damage, aneuploidy and tumorigenesis (83). 
Furthermore, inhibition of autophagy shows up a fundamental defect in DNA repair: 
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loss of autophagy leads to reduced levels of Chk1, an essential factor for homologous 
recombination, and to a corresponding deficit in DNA repair of double strand breaks 
(84). This is explained by the fact that inhibition of autophagy causes elevated 
proteasomal activity with enhanced Chk1 degradation (84). 
The idea that autophagy can be selective for particular protein targets is now 
well-established and is pivotal for explaining some important feedback pathways. Gao 
et al. ascribed to autophagy an essential role for the disposal of the Dishevelled (Dvl) 
protein under conditions of nutrient stress and demonstrated an inverse correlation 
between autophagic activity and levels of cytoplasmic Dvl, hence, also the intensity of 
Wnt signaling (85). The term “signalphagy” was recently coined by Belaid et al. for 
dedicated, selective autophagy which aims to regulate levels of particular, individual 
signaling proteins (86). These authors demonstrated that autophagy is responsible for 
the rapid and selective degradation of active RHOA-GTP (87). Interestingly, the 
inactive form of RHOA was subject to proteasomal degradation. The basis for this 
selective degradation is the specificity of p62 and related autophagy receptor/adaptor 
proteins for individual, ubiquitinated targets, mediating their association with lipidated 
LC3 at the developing autophagosome (87).  
P62 is the most studied of the receptor/adaptor proteins selectively targeted for 
autophagic degradation. Its gene, SQSTM1, is a target for transactivation by the 
transcription factor Nrf2 (5). SQSTM1 transactivation by Nrf2 is induced as a part of 
the overall anti-oxidant and detoxification response, seen, for example, under 
conditions of increasing intracellular ROS concentrations. Interestingly, p62 plays an 
essential retrograde role in controlling levels of Nrf2 which is vitally important for 
maintaining the redox balance in the cell (Fig. 4) (5,88). The transcription factor Nrf2 is 
subject to ubiquitination through the binding of kelch-like ECH-associated protein 1 
15 
 
(Keap1), a component of a Cullin-3-type ubiquitin ligase, and is retained in the 
cytoplasm and targeted for degradation in the 26 S proteasome (Fig. 4). Since p62 
serves as a specific receptor for Keap1, however, regulating its elimination by 
autophagy (Fig. 4) (88), this mechanism provides “chronic oxidative stress signaling 
through a feed-forward loop” (5) which, however, is conditional on a functional 
autophagic flux.  
This loop concept leaves us asking how the p62 function is regulated. One way 
is clearly its transcriptional upregulation as a target of Nrf2-dependent transcription. 
But what if p62 levels are low, and Nrf2 is entirely bound up by Keap1 and subject to 
degradation? Ichimura et al. have demonstrated that a specific mTORC1-dependent 
phosphorylation of p62 on Ser351 causes significantly increased affinity of p62 for 
Keap1 with concomitant degradation through autophagy (89). Furthermore, recent 
findings have established that sestrin expression also activates p62/Keap1 binding and 
autophagic degradation (90). Thus, p62 activation by phosphorylation and/or by sestrin 
binding promise effective regulation of Keap1 levels and stabilization of Nrf2 with 
consequent transcription of its anti-oxidant program as needed (Fig. 4).  
 
MiT/TFE transcription factors require ATG5/ATG9 for regulation of 
lysosomal/autophagy protein expression in mitophagy  
Already from Fig. 1, one can see that the lysosome plays a central role in the regulation 
of autophagy and metabolism (24,26). The lysosome is integrally involved in the 
initiation of autophagy and, of course, lysosomal degradative capacity must also be 
regulated according to demand. The transcription factors mainly delegated for this 
purpose are in the MiT/TFE family, basic helix-loop-helix leucine zipper transcription 
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factors binding to the E-box core sequence (CANNTG) (91). This family includes the 
frequently studied transcription factor EB (TFEB). Members of this family associate 
with the Rag GTPase proteins and are phosphorylated by active mTORC1 on the 
lysosomal outer surface, being subsequently sequestered in the cytosol bound to the 
chaperone 14-3-3. In response to nutrient starvation; however, inactivation of 
mTORC1 is rapidly followed by TFEB dephosphorylation, its translocation into the 
nucleus and transactivation of numerous genes for autophagy and for lysosomal 
biogenesis (Fig. 5). These include lysosomal acid lipase, the proton pump v-ATPase, 
p62 and ATG9 (26,92). 
Just how closely TFEB and other MiT/TFE transcription factors are integrated 
with the process of autophagy was recently documented (8). These investigators 
demonstrated that for mitophagy, a special form of autophagy modified for the 
degradation of dysfunctional mitochondria, TFEB translocation into the nucleus 
required the functions of both ATG5 and ATG9 (Fig. 5). Mitophagy aims to achieve 
lysosomal degradation of dysfunctional mitochondria, i.e. comparatively large 
organelles demanding significant upregulation of autophagic and lysosomal capacity. 
It is a form of selective autophagy and an essential mitochondrial quality control 
function (93). Following loss of the mitochondrial membrane potential or accumulation 
of misfolded proteins in a mitochondrion, PTEN-induced kinase 1 (PINK1) accumulates 
on the outer mitochondrial membrane where it recruits from the cytosol the E3 ubiquitin 
ligase, parkin, concomitantly activating/phosphorylating this latent enzyme to 
ubiquitinate proteins on the outer mitochondrial membrane, thereby marking the 
damaged organelle for binding by autophagy receptor/adaptors (Fig. 5). Parkin 
activation takes place as a two-step event; PINK1 phosphorylates parkin on ser65 in 
its ubiquitin-like domain, and in parallel, also phosphorylates ubiquitin (94,95). Though 
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autophagy receptors/adaptors such as p62 and optineurin are known to bind the 
ubiquitin chains on damaged mitochondria, recent results have established that the 
NDP52 and optineurin, not p62, are the primary receptors/adaptors for PINK1- and 
parkin-mediated mitophagy, providing the bridge to lipidated LC3 (96). Furthermore, 
these receptors are responsible for the recruitment of ULK1/2, DFCP1 and WIPII (not 
shown in Fig. 5) to early phagophores forming adjacent to the mitochondria (96). 
That TFEB activation, translocation and functional transactivation of needed 
target genes should require parkin, ATG5 and ATG9 illustrates the interdependence 
between early stages of phagophore construction (97-99) and the projected 
transcriptional needs of an ambitious degradative project like mitophagy (8). 
Noteworthy is the fact that such interdependence is not seen when TFEB activation 
occurs after nutrient starvation, a stimulus requiring much less autophagic/lysosomal 
biogenesis. In this case, TFEB activation, nuclear translocation and transcriptional 
activity are ATG5-, ATG9- and parkin-independent (8). 
 
Autophagy and the NFκB/IKK activation are interdependent 
NFκB can transactivate many autophagy-relevant genes, including Beclin 1. 
Significantly, NFκB plays a central role in transactivating genes involved in 
inflammatory responses and the general tendency of NFκB-regulated transcription is 
pro-autophagic. Several years ago, it became clear that that signaling pathways 
leading to NFkB activation also overlap with autophagy (100-102). The IκB kinase (IKK) 
brings about the activation of NFκB by committing IκB to proteasomal degradation. For 
IKK activation, TGF-β activated kinase 1 (TAK1) and its binding proteins, TAB2 and 
TAB3 are required. However, since TAB2 and TAB3 exist as complexes with the 
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autophagy protein Beclin 1, TAK1 and Beclin 1 are competitors. Beclin 1 has many 
other interactions, all of which limit its availability, but upon its release from these 
complexes, it can initiate autophagy and concomitantly, with the availability of TAB2 
and TAB3, the IKK-dependent activation of NFκB can begin (Fig. 6).  
Surprisingly, not only does autophagy require the release of Beclin 1 together 
with IKK activation, but also reciprocally, autophagy must be functional in order for 
NFκB activation to occur (103). Starvation or drugs like the mTORC1 inhibitor 
rapamycin or the p53 inhibitor pifithrin-α which stimulate autophagy also strongly 
stimulate activation of IKK, followed by the translocation of NFκB/p65Rel into the 
nucleus and its activation. In wild-type MEF, the activation of the canonical NFκB 
pathway must be accompanied by initiation of functional autophagy (103); thus, in 
Atg5- or Atg7-deficient MEF, the NFκB pathway remains largely inactive (Fig. 6). Here 
again clearly, there is interdependence for function between autophagy and a 
transcription factor important for stress response and especially inflammatory 
response.  
 
Concluding Remarks 
Several lines of evidence indicate that autophagy exists as a pathway closely 
integrated with the stress response network, because, while autophagy is a major 
functional target of stress responses, it is also influences the transcription factor activity 
regulating these responses. We can recognize various ways in which individual ATG 
proteins can modulate and amplify the activities across the entire stress network.    
The “connectedness” of ATG proteins in the network is important for 
understanding the complexity of the choices available to the cell following induction of 
19 
 
autophagy. Beclin 1 plays essential roles in many membrane trafficking pathways 
(17,18), competes with NFκB activation (102,103) and serves as a balance point 
between apoptosis and autophagy. Similarly, ATG5 can be degraded by calpain to 
produce a pro-apoptotic fragment (104,105), but also, importantly, ATG5 upregulation 
can act to induce p53 expression and activation (68,69), setting off a stress response 
together with the initiation of autophagy. ATG7, besides functioning as an E1-ligase in 
the conjugation reactions producing ATG12-ATG5 and LC3-PE, serves as an essential 
accessory protein required for p53-dependent transactivation of p21CDKN1A and growth 
arrest in DDR (35), but also subtly represses p53-dependent Puma, Noxa and Bax 
transactivation (35) and interacts with acetylated FOXO1 to induce autophagy (78,79). 
In a clinical context, unfortunately, all these examples of integration between 
autophagy and stress responses underline how difficult it will be to intervene selectively 
with drugs against the helpful survival facility which autophagy provides to established 
tumor cells (106,107). While the stress response and autophagy are evolutionary 
programs which help to raise the bar against early oncogenesis, in practice they also 
assure some degree of chemotherapy resistance in established tumors. To date, no 
protocol has been devised which could eliminate autophagy without incapacitating 
stress responses and increasing the long-term oncogenic risks. It is therefore the hope 
that further investigation in this area will help to achieve this goal in the near future. 
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Figure Legends 
Fig. 1. Pathways regulating stress response and ultimately mTORC1. Red arrows 
delineate the pathways which are activated after DNA damage or oxidative stress, 
leading finally to the initiation of autophagy. At the site of DNA double strand breaks, 
monomer ATM phosphorylates and activates Chk2, which then phosphorylates p53, 
leading to its tetramerization and activation. The transactivation of p21CDKN1A 
establishes cell cycle arrest, while other p53 transactivation targets, pro-autophagic 
proteins like sestrins and DRAM, metabolic effectors such as TIGAR, but also proteins 
like Puma, Noxa and Bax which potentially induce apoptosis, can all be contribute. P53 
plays a complex role, because after DNA damage, activated p53 is also translocated 
to the cytoplasm where it instigates via LKB1 the phosphorylation/activation of AMPK.  
Cells regulate mTORC1 with multiple sensor pathways. Under all stress conditions, 
AMPK plays a central role because it determines the phosphorylation/activation of 
TSC1/2 (P), regulating Rheb GTPase and thus its conversion to the inactive, GDP-
bound form whiuch causes mTORC1 inactivation and displacement from its lysosomal 
tethers. This relieves the inhibitory block on autophagy (X). AMPK is able to detect 
energy charge (see green inhibitory arrow on AMPK leading from glucose and O2). 
Growth factor (GF) stimulation is essential for maintaining TSC1/2 in an inactive state, 
antagonizing the role of AMPK [see GF, growth factor Receptor (R), PI3K and AKT 
with green inhibitory arrows in the lower left quadrant]. Furthermore, a sufficiency of 
essential amino acids is required for mTORC1 tethering to the Rag GTPases; as with 
Rheb inactivation, a lack of amino acids causes mTORC1 displacement and 
inactivation. Thus, mTORC1 is displacement by any of these sensor pathways causes 
a fundamental “switch” which triggers the spontaneous initiation of autophagy, but also 
is felt overall in the cell as shift from anabolic to catabolic metabolism.  
ROS accumulation resulting from metabolic imbalance or mitochondrial damage allows 
oxidized (ox) ATM dimers to phosphorylate and activate AMPK directly with 
consequent TSC1/2 activation, and Rheb and mTORC1 inactivation. Interestingly, 
after glucose starvation, AMPK can also send a stress signal upstream, 
phosphorylating and activating p53 (see yellow arrow), setting off a stress response, 
and potentially inducing mitochondrial (“Mito”) damage and apoptosis (see yellow 
dotted arrow).  
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Under stress-free conditions, cytoplasmic p53 (cyto-p53; upper right quadrant) 
regulates cell metabolism by modulating the pentose phosphate pathway (PPP; green 
inhibitory arrow) and by inhibiting autophagy “tonically” by complexing with FIP200 
(green inhibitory arrow).  
 
Fig. 2.  ATG5 and ATG7 impact on p53 pathways in stress response. ATG7 is an 
essential accessory protein for the activation of p53-dependent transactivation of 
p21CDKN1A leading to cell cycle arrest (see light blue arrows). ATG7-p53 complexes are 
to be found in both cytoplasm and nucleus of normal cells. Ectopic ATG7 expression 
induces autophagy. 
Ectopic ATG5 expression induces autophagy, too, but it also stimulates p53 
upregulation, activation and transactivation of p21CDKN1A. The question mark (?) points 
to a speculative stimulatory loop which may be responsible for such p53 
upregulaion/activation after ectopic ATG5 expression. This proposal is based on the 
positive feed-forward loop between AMPK, which acts to phosphorylate p53. This is 
followed by p53-dependent transactivation of sestrin and a resulting potentiation of 
AMPK activation (see red arrows). Furthermore, ATG5 is found in significant amounts 
in the nucleus where, if overexpressed, it binds to survivin/BIRC5. There, ATG5, by 
competing with Aurora B, interferes with the function of the chromosome passenger 
complex at the centromere, inducing mitotic catastrophe.  
 
Fig. 3. A feedback regulation by ATG7 on FOXO1. FOXO3 transcription factor 
activity antagonizes FOXO1 expression in the nucleus; thus negatively regulating 
autophagy. Following an inactivation of the Sirt2 deacetylase caused by oxidative 
stress, acetylated cytoplasmic FOXO1 accumulates in the cytoplasm forming a 
complex with ATG7 which is retained in the cytoplasm. Autophagy is induced by the 
acetylated FOXO1/ATG7 complex. This mechanism for autophagy induction is 
believed to suppress tumor xenograft growth in nude mice in an autophagy-dependent 
manner.  
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Fig. 4. By regulating Keap1 degradation, p62-dependent selective autophagy 
creates feedback loops for Nrf2 amplification in stress response pathways. 
Because SQSTM1, the gene for p62, is transactivated by Nrf2, a feed forward loop is 
established: when ROS levels rise; Nrf2 plays an important role in regulating genes 
needed for anti-oxidant (Anti-ox) proteins. Keap1 as an ubiquitin ligase which regulates 
levels of the Nrf2 transcription factor, determining its proteasomal degradation. 
However, since the autophagic cargo receptor, p62, can complex with Keap1, this 
complex, together with aggregates (Ag) of other ubiquitinated proteins, are 
sequestered at the developing phagophore (Ph) and degraded. Interestingly, the 
affinity of p62 for Keap1 is increased following its activation by sestrin binding (not 
shown) or following phosphorylation (P) by mTORC1 and other unknown kinases, thus 
regulating the rate of Keap1 degradation in autophagy. 
 
Fig. 5. MiT/TFE transcription factors require parkin, ATG5 and ATG9 for 
regulation of autophagic/lysosomal gene expression in mitophagy. Mitophagy 
represents a massive, selective autophagic degradation requiring increased resources 
in both autophagic and lysosomal proteins. Their expression depends on the MiT/TFE 
transcription factors (here exemplified by TFEB). These transcription factors are 
retained in the cytoplasm with the chaperone 14-3-3 after their phosphorylation by 
active mTORC1. Following mitochondrial dysfunction with accompanying ROS 
production, the PINK1 kinase recruits the E3 ubiquitin ligase, parkin, to the outer 
mitochondrial membrane where it ubiquinates numerous mitochondrial surface 
proteins. These then can serve as targets for autophagy receptor/adaptors, bridging to 
the LC3 on the phagophore (Ph). TFEB activation and translocation into the nucleus 
take place in a parkin, ATG5 and ATG9-dependent manner which allows successful 
transactivation of numerous lysosomal and autophagy genes. The role of ATG5 and 
ATG9 in contributing to the formation of the early phagophore is the probable 
mechanism for their role in TFEB translocation though some evidence suggests that 
both ATGs also enter into the nucleus.8 Glucose deprivation also stimulates TFEB 
activation and translocation, but is ATG5 and ATG9 independent.   
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Fig. 6. Functions required for NFκB transcription factor activation overlap with 
the induction of autophagy, because, for NFκB activation, a functional 
autophagic pathway is required. NFκB is normally retained the cytoplasm, bound to 
its inhibitor, IκB. NFκB is activated by the IKK complex which displaces the IκB for 
proteasomal degradation. For IKK function, however, the TGF-β activating kinase 1 
(TAK1) is required, together with its co-factors TAB2 and TAB3. Since these two co-
factors exist as complexes with Beclin 1, which itself is in an equilibrium with Bcl-2 as 
well, NFκB activation can only occur in parallel with autophagy as a consequence of 
shifts in the equilibria of TAB2 and TAB3 with Beclin 1, making them available for IKK 
activation, but at the same time releasing free Beclin 1 to initiate autophagy.  
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